Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

DGHCX AllianzGI Health Sciences D

  • Fund
  • DGHCX
  • Price as of: Dec 22, 1999
  • $13.72
  • + $0.51
  • + 3.86%
  • Category
  • Health & Biotech Equities

DGHCX - Profile

Vitals

  • YTD Return 0.0%
  • 3 Yr Annualized Return N/A
  • 5 Yr Annualized Return N/A
  • Net Assets $208 M
  • Holdings in Top 10 31.5%

52 WEEK LOW AND HIGH

$13.72
N/A
N/A

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.46%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 76.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.73%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name AllianzGI Health Sciences Fund
  • Fund Family Name Allianz Funds
  • Inception Date Dec 31, 1996
  • Shares Outstanding N/A
  • Share Class D
  • Currency USD
  • Domiciled Country United States
  • Manager John R. Schroer

Fund Description

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio managers consider health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences or that otherwise promote healthy living. The fund will invest primarily in common stocks and other equity securities.

DGHCX - Performance

Return Ranking - Trailing

Period DGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 0.0% -14.9% 36.8% 95.54% 5
1 Yr N/A -14.8% 43.9% N/A N/A
3 Yr N/A * -7.5% 18.5% N/A N/A
5 Yr N/A * 9.3% 22.0% N/A N/A
10 Yr N/A * 6.1% 17.5% N/A N/A

* Annualized


Return Ranking - Calendar

Period DGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 0.0% -29.8% 2.6% 8.18% 1
2015 0.0% -20.4% 14.5% 24.55% 2
2014 0.0% -5.8% 33.7% 94.55% 5
2013 0.0% -2.6% 65.2% 97.25% 5
2012 0.0% -5.3% 36.5% 87.38% 5

Total Return Ranking - Trailing

Period DGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD N/A -14.9% 36.8% N/A N/A
1 Yr N/A -18.3% 43.9% N/A N/A
3 Yr N/A * -14.2% 18.5% N/A N/A
5 Yr N/A * 9.1% 22.0% N/A N/A
10 Yr N/A * 6.1% 17.2% N/A N/A

* Annualized


Total Return Ranking - Calendar

Period DGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 N/A -25.1% 6.3% N/A N/A
2015 N/A -16.6% 39.1% N/A N/A
2014 N/A -5.8% 100.0% N/A N/A
2013 N/A -5.1% 398.7% N/A N/A
2012 N/A -2.6% 475.8% N/A N/A

NAV & Total Return History

DGHCX - Holdings

Filings data as of: Sep 30, 2015

Concentration Analysis

DGHCX Category Low Category High DGHCX % Rank Quintile
Net Assets 208 M 18.6 M 47 B 36.61% 5
Number of Holdings 78 31 361 21.43% 3
Net Assets in Top 10 64.1 M 11 M 20.2 B 36.61% 5
Weighting of Top 10 31.5% 19.8% 71.2% 40.18% 5

Top 10 Holdings

  1. Shire PLC 2.65%
  2. Vertex Pharmaceuticals Inc 2.70%
  3. UnitedHealth Group Inc 4.21%
  4. AbbVie Inc 3.29%
  5. Celgene Corp 3.74%
  6. Eagle Pharmaceuticals Inc 3.09%
  7. Regeneron Pharmaceuticals Inc 3.02%
  8. Alexion Pharmaceuticals Inc 3.08%
  9. Mylan NV 2.75%
  10. Bristol-Myers Squibb Company 2.96%

Asset Allocation

Weighting Category Low Category High DGHCX % Rank Quintile
Stocks
96.10% 91.83% 99.98% 32.14% 4
Cash
3.90% -0.04% 5.66% 5.36% 1
Preferred Stocks
0.00% 0.00% 4.16% 18.75% 5
Other
0.00% -5.64% 5.15% 18.75% 5
Convertible Bonds
0.00% 0.00% 0.46% 2.68% 5
Bonds
0.00% 0.00% 4.69% 7.14% 5

Stock Sector Breakdown

Weighting Category Low Category High DGHCX % Rank Quintile
Healthcare
93.95% 11.15% 99.98% 27.68% 3
Technology
1.58% 0.00% 65.49% 19.64% 3
Consumer Defense
0.55% 0.00% 1.65% 8.04% 1
Utilities
0.00% 0.00% 0.95% 1.79% 5
Real Estate
0.00% 0.00% 1.52% 1.79% 5
Industrials
0.00% 0.00% 8.26% 8.04% 5
Financial Services
0.00% 0.00% 2.90% 6.25% 5
Energy
0.00% 0.00% 0.09% 1.79% 5
Communication Services
0.00% 0.00% 0.00% 0.89% 5
Consumer Cyclical
0.00% 0.00% 7.41% 7.14% 5
Basic Materials
0.00% 0.00% 2.25% 6.25% 5

Stock Geographic Breakdown

Weighting Category Low Category High DGHCX % Rank Quintile
US
84.30% 60.72% 99.98% 32.14% 3
Non US
11.80% 0.00% 34.72% 13.39% 2

DGHCX - Expenses

Operational Fees

DGHCX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.46% 0.10% 4.31% 31.25% 3
Management Fee 1.20% 0.09% 1.25% 1.79% 5
12b-1 Fee 0.25% 0.00% 1.00% 8.86% 3
Administrative Fee 0.40% 0.01% 0.40% 1.54% 5

Sales Fees

DGHCX Fees (% of AUM) Category Low Category High DGHCX Rank Quintile
Front Load N/A 2.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

DGHCX Fees (% of AUM) Category Low Category High DGHCX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

DGHCX Fees (% of AUM) Category Low Category High DGHCX Rank Quintile
Turnover 76.00% 0.00% 699.00% 8.93% 5

DGHCX - Distributions

Dividend Yield Analysis

DGHCX Category Low Category High DGHCX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

DGHCX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

DGHCX Category Low Category High DGHCX % Rank Quintile
Net Income Ratio -0.73% -2.22% 1.46% 50.00% 4

Capital Gain Distribution Analysis

DGHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

DGHCX - Managers

John R. Schroer

Lead Manager

Start Date

Jan 13, 2014

Tenure

1.8

Tenure Rank

29.6%

Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. Mr. Schroer has more than 20 years of investment-industry experience. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. an M.B.A. in finance from the University of Wisconsin.


Michael Dauchot

Manager

Start Date

Mar 01, 2005

Tenure

10.67

Tenure Rank

15.0%

Dr. Dauchot, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 1999. He is part of the Health Care team, focusing on medical technology and emerging pharmaceuticals. Dr. Dauchot has 17 years of investment-industry experience. He previously worked at Pequot Capital Management and BancBoston Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an M.B.A. from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine.


Tenure Analysis

Category Low

0.3

Category High

20.1

Category Average

9.06

Category Mode

0.7